135
Participants
Start Date
September 30, 2011
Primary Completion Date
December 31, 2016
Study Completion Date
December 31, 2016
PEGASYS
Patient will start at 45 micrograms per week and gradually increase to 180 micrograms per week. Pegasys will be supplied in prefilled syringes and are to be given subcutaneously.
Aspirin
81 or 100 mg daily.
Icahn School of Medicine at Mount Sinai, New York
Memorial Sloan-Kettering Cancer Center, New York
Weill Cornell Medical College, New York
Ospedale San Maartino Genova, Genova
Geisinger Cancer Center, Danville
University of Pennsylvania, Philadelphia
Georgetown University Medical Center, Washington D.C.
University of Maryland, Baltimore
San Matteo Hospital, Pavia
Wake Forest University Baptist Medical Center, Winston-Salem
Duke University Medical Center, Durham
Emory Hospital, Atlanta
John H. Stroger Hospital of Cook County, Chicago
University of Illinois at Chicago, Chicago
University of Kansas Cancer Center, Westwood
University of Utah, Salt Lake City
Mayo Clinic, Scottsdale
The Palo Alto Clinic, Palo Alto
Ospedale Riuniti de Bergamo, Bergamo
University Of Florence, Florence
Universita Cattolica del Sacro Cuore, Rome
Myeloproliferative Disorders-Research Consortium
NETWORK
National Cancer Institute (NCI)
NIH
Roche Pharma AG
INDUSTRY
Ronald Hoffman
OTHER